From August 28 to September 2, 2026, four members from the College of Pharmacy presented their research on medication use, safety and health outcomes across diverse populations at the 42nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE 2026).
Held in Milan, Italy this year, these researchers showcased pharmacoepidemiology, medication safety, real-world evidence and health outcomes research in pregnancy, pediatric populations and people living with chronic conditions.
Presentations:
Naira Hany (PhD Candidate, Eltonsy Lab): “Safety of Vedolizumab and Ustekinumab in Pregnant Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.” Presented as part of the Biologics Spotlight Poster Session, the study evaluated how two biological therapies for inflammatory bowel disease can affect maternal and fetal safety during pregnancy. The study was conducted by Naira Hany and Sherif Eltonsy.
Mira Safa (PhD Candidate, Kowalec Lab): “Association of Neurofilament Light Chain and Glial Fibrillary Acidic Protein Levels with Comorbid Depression in Multiple Sclerosis.” The study looked at the relationship between depression and markers of brain inflammation in people with multiple sclerosis. The study also looked at how these relationships may change over time. Coauthored by Ruth Ann Marrie, Ronak Patel, Ronald Booth, John D. Fisk, Charles N. Bernstein and Kaarina Kowalec.
Dr. Payam Peymani, Assistant Professor, pharmacy: “Trends in Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors During Pregnancy in Canada, 2015–2023.” The study examined how GLP-1 receptor agonists and SGLT2 inhibitor use has changed during pregnancy in Canada. Coauthored by Laila Aboulatta, Roxana Dragan, Mohd Wasif Khan and Sherif Eltonsy.
Dr. Sherif Eltonsy, Associate Professor, pharmacy: “Utilization Trends of Gabapentinoids Among Pediatric Populations in Manitoba, Canada, and Japan.” This study looked at gabapentinoids prescription rates over a span of 15–27 years in children and adolescents in both Manitoba and Japan. Coauthored by Kenji Momo and co-presented by Laila Aboulatta.
Dr. Sherif Eltonsy, Associate Professor, pharmacy:“Outpatient Antibiotic Utilization During Pregnancy in Manitoba, Canada: A 23-Year Population-Based Study” This study looked at how antibiotic use has changed over a 23-year period. And how the COVID-19 pandemic changed antibiotic use. Coauthored by Kaarina Kowalec, Lisa Lix, Mina Tadrous, Joseph Delaney, Roxana Dragan. And co-presented by Laila Aboulatta.